Avantor

For decades, high-performance silicones called fluorosilicones have been trusted in defense technology for their durability and resistance to harsh conditions. Gain insights from our engineers on selecting the right fluorosilicones to optimize critical defense systems. https://lnkd.in/gCjQrMEF

What an incredible week at the Avantor Biopharma Forum in Taiwan and South Korea! Our inspiring speakers and industry experts shared groundbreaking techniques and best practices to enhance biologic process efficiency. A big thanks to our distributors Echo Chemical Co., Ltd and ChainHome Biotech Inc. in Taiwan for their support! It was encouraging to see so many professionals come together to advance the #biopharmaceutical manufacturing industry.

With a growing number of regulatory approvals for gene therapy and deep pipeline of investigational candidates, manufacturers face pressure to get these new therapies to market quickly. Ger Brophy tackles emerging scale-up efficiency and quality challenges, with an in-depth look at optimizing viral vector production, managing costs, and collaborating on industry standardization and automation in this latest European Biopharmaceutical Review (EBR) article. Read the article here: https://lnkd.in/gMaHvAaZ

At Avantor, cultivating a culture of inclusion and belonging is core to our mission of setting science in motion to create a better world. The Philadelphia Business Journal recently recognized Avantor as a Business of Pride Champion for our efforts supporting the LGBTQ+ community. Read more about how Avantor creates safe spaces and advocates for change here: https://lnkd.in/gcT59NJX #Philadelphia #Pride

As science evolves, so do the ways our associates support it. We know the work we do every day plays a critical role in making life-changing medicines available to patients, and that ignites our passion to drive our customers’ success. Explore how we continue to build on our legacy of innovation with our President & CEO Michael Stubblefield, our EVP, Chief Financial Officer R. Brent Jones, our SVP, General Manager, Lab Specialty Business Claudia Berrón, and our EVP, Chief Human Resources Officer Brittany Hankamer.  

We are pleased to announce that Corey Walker has rejoined Avantor as President of Laboratory Solutions. In this role, he oversees our third-party products, proprietary lab platforms and Avantor Services and is responsible for our Global Supply Chain organization. https://lnkd.in/gC5VyT4r   Welcome back, Corey!

New EU environmental regulations have prompted biomanufacturers to rethink the use of an industry-favored method of cell lysis, Octoxynol-9. To ensure patient safety, it’s time to take a closer look at our novel reagent — an effective alternative without the harmful, endocrine-disrupting activities. https://lnkd.in/eFvcAKvH

Today we commemorate Juneteenth, celebrating the emancipation and empowerment of Black people in the United States.   At Avantor, we are committed to creating a fully inclusive culture. Our Global Black Associate-Centric Team is recognizing the importance of Juneteenth by hosting discussion sessions that celebrate and reflect on the contributions, achievements, and cultural heritage of Black individuals and communities.   Learn more about our commitment to diversity, equity, inclusion, and belonging here: https://lnkd.in/e7FabCAy

As innovation advances, it is essential we protect our environment and communities by embedding sustainable business practices into our operations. Last year, for example, we completed 20+ climate-related projects and achieved our 2025 greenhouse gas reduction targets two years ahead of schedule. Read more in our 2024 Sustainability Report: https://lnkd.in/gAyfvRiq

New treatment modalities bring life-changing medicines to those in need, but they also create scale-up and manufacturing challenges. Keeping up with demand requires new technology expertise, skillsets, and processes. Learn more about the quality controls and regulatory expertise we bring to the table to give our customers the edge from our EVP of Bioscience Production, Benoit Gourdier, and VP Commercial & GM of Bioscience Production AMEA, Narayana Rao R.